1. Bioactivation of cyclopropyl rings by P450: an observation encountered during the optimisation of a series of hepatitis C virus NS5B inhibitors
- Author
-
Xiaohua Stella Huang, Kyle J. Eastman, Kyle Parcella, Benjamin M. Johnson, John F. Kadow, Xiaoliang Zhuo, Juliang Zhu, Yue-Zhong Shu, Nicholas A. Meanwell, Kap-Sun Yeung, and Yingzi Wang
- Subjects
0301 basic medicine ,Stereochemistry ,Health, Toxicology and Mutagenesis ,Hepacivirus ,Viral Nonstructural Proteins ,Toxicology ,Ring (chemistry) ,Hydrogen atom abstraction ,Antiviral Agents ,030226 pharmacology & pharmacy ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cytochrome P-450 Enzyme System ,Animals ,Humans ,Moiety ,Benzofuran ,NS5B ,Pharmacology ,Drug discovery ,General Medicine ,Glutathione ,Rats ,030104 developmental biology ,chemistry ,Benzamides ,Conjugate - Abstract
1. Due to its unique C-C and C-H bonding properties, conformational preferences and relative hydrophilicity, the cyclopropyl ring has been used as a synthetic building block in drug discovery to modulate potency and drug-like properties. During an effort to discover inhibitors of the hepatitis C virus non-structural protein 5B with improved potency and genotype-coverage profiles, the use of a pyrimidinylcyclopropylbenzamide moiety linked to a C6-substituted benzofuran or azabenzofuran core scaffold was explored in an effort to balance antiviral potency and metabolic stability. 2. In vitro metabolism studies of two compounds from this C6-substituted series revealed an NADPH-dependent bioactivation pathway leading to the formation of multiple glutathione (GSH) conjugates. Analysis of these conjugates by LC-MS and NMR demonstrated that the cyclopropyl group was the site of bioactivation. Based on the putative structures and molecular weights of the cyclopropyl-GSH conjugates, a multi-step mechanism was proposed to explain the formation of these metabolites by P450. This mechanism involves hydrogen atom abstraction to form a cyclopropyl radical, followed by a ring opening rearrangement and reaction with GSH. 3. These findings provided important information to the medicinal chemistry team which responded by replacing the cyclopropyl ring with a gem-dimethyl group. Subsequent compounds bearing this feature were shown to avert the bioactivation pathways in question.
- Published
- 2017